8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T82821 | BRD9 Degrader-1 | Epigenetic Reader Domain | |
BRD9 Degrader-1 functions as a BRD9 degrader, demonstrating micromolar binding affinity towards BRD9 and nanomolar affinity for the ternary complex involving BRD9 and VCB [1]. | |||
T12560 | PROTAC BRD9 Degrader-1 | Epigenetic Reader Domain | |
PROTAC BRD9 Degrader-1 is a lead PROTAC BRD9 chemical degrader with IC50 of 13.5 nM. | |||
T79889 | DBr-1 | Epigenetic Reader Domain | |
DBr-1 is a potent degrader of BRD9 [1]. | |||
T77975 | PROTAC BRD9 Degrader-6 | Epigenetic Reader Domain | |
PROTAC BRD9 Degrader-6, with an IC50 value of 0.13 nM, is a potent degrader of BRD9 suitable for research on BAF complex-related disorders [1]. | |||
T81382 | PROTAC BRD9 Degrader-7 | PROTACs | |
PROTAC BRD9 Degrader-7 is a selective and orally active BRD9 degrader with a DC50 of 1.02 nM and demonstrates superior pharmacokinetics, evidenced by a Cmax of 3436.95 ng/mL [1]. | |||
T78660 | (S,R)-CFT8634 | Epigenetic Reader Domain | |
(S,R)-CFT8634 is a selective and orally active BRD9 protein degrader with potential for researching BRD9-mediated disorders, such as abnormal cellular proliferation[1]. | |||
T74919 | QA-68 | ||
QA-68 (QA-68-ZU81), a potent bromodomain-containing protein 9 (BRD9) degrader, effectively inhibits cell cycle progression and cell colony formation. Demonstrating antiproliferative activity, this compound is particularl... | |||
T75135 | FHD-609 | ||
FHD-609, an inhibitor and degrader of BRD9 (bromodomain-containing protein 9), targets the ncBAF complex and is useful for researching a broad spectrum of cancers with mutations in a BAF complex subunit. When used alongs... |